Although almost 90% of VFC-eligible children born during 2011-2020 received the measles, mumps, and rubella (MMR) vaccine, just 61% to 65% received a combined series of seven pediatric vaccines, "highlighting room for improvement," reported Madeleine Valier, MPH, of the CDC National Center f...
February 25, 2010(UPDATED March 3, 2010)— The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted on February 24 to recommend the use of a 13-valent pneumococcal conjugate vaccine (PCV13), which provides broader protection for young children...
public health expertsupdatedpneumococcal vaccination recommendations for adults 19 and older. The updated guidelines recommend that adults who have only had the pneumococcal polysaccharide vaccine (PPSV) get a polysaccharide conjugate vaccine (PCV). ...
As pneumonia can be a serious and sometimes deadly complication of the flu, especially for older adults, the CDC also recommends the pneumococcal vaccine for those 65 and over. Other common-sense steps you can take to avoid the flu include frequent hand washing, avoiding people who are sick,...
The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday.
We really prioritize underserved communities to improve vaccine equity, to uphold health equity, to improve health equity. And we do this on a pretty giant scale. In 2022 alone, for example, VFC distributed over 71.5 million doses of pediatric vaccines to participating provider ...
- 《Pediatric Infectious Disease Journal》 被引量: 532发表: 2012年 Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis In March 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced the seven-...
Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease Study Objective To review five cases of severe adverse reactions after vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in pedia... J Han,O Kemiki,LL Hsu,... - 《Pha...
Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--... On March 12, 2010, the Advisory Committee on Immunization Practices (ACIP) published recommendations for use of a newly licensed, 13-val...
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia - Updated analysis using Wo... Background: A World Health Organization (WHO) working group in 2001 developed a method for standardizing interpretation of chest radiographs in...